Thomas Lagrelius

Thomas Lagrelius practices at Torrance Memorial Medical Center in Torrance, California, part of Cedars-Sinai Health System.

Thomas Lagrelius' NPI, 1386690915, was assigned on May 25, 2006. Thomas Lagrelius graduated from University Of Washington School Of Medicine in 1969. Thomas Lagrelius holds California license G22952.

Thomas Lagrelius' primary practice is Torrance Memorial Medical Center, at 3330 Lomita Blvd, Torrance, CA 90509 in Los Angeles County. The practice phone is (310) 325-9110.

Thomas Lagrelius' primary practice is Torrance Memorial Medical Center in Torrance, California, part of Cedars-Sinai Health System. The medical group on file is Skypark Preferred Family Care. Dmand AI also links Thomas Lagrelius to 1 more group practice or clinic, 1 home health agency, 1 hospice and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Thomas Lagrelius practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Thomas Lagrelius' primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Thomas Lagrelius is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Thomas Lagrelius' licenses on file in 2 states: California and Ohio.

Dmand AI lists acid reflux, acne, acute gastroduodenitis, acute respiratory failure, acute sinusitis, acute skin infection, alzheimer's disease and aneurysm among the conditions Thomas Lagrelius treats.

CMS data shows 39,207 Medicare services from Thomas Lagrelius across 25 procedure codes in 2024, for 267 Medicare patients. Medicare paid $121,933 for them.

CMS counts 267 Medicare patients who saw Thomas Lagrelius in 2024. The largest group is 75 to 84, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Thomas Lagrelius' median patient age at 81, with 48% women.

In 2024, Thomas Lagrelius wrote 4,242 Medicare Part D claims for 255 patients. 78% of them were for generic drugs. CMS names the drug for 3,667 of them, across 100 drugs with 11 or more claims each, at $587,116 in total drug cost. In 2023, CMS named 3,694 claims across 94 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Thomas Lagrelius for performance year 2024, reported individually. Thomas Lagrelius accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 17 procedures of removal of skin lesions by Thomas Lagrelius, more than 63% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 21 general payments to Thomas Lagrelius from 12 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $249.

Dmand AI lists 3 awards for Thomas Lagrelius, most recently Castle Connolly Top Doc 2000 through 2014 in 2022.

Thomas Lagrelius graduated from University Of Washington School Of Medicine in 1969.

Thomas Lagrelius is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.